In RCC, the activation of the PI3K/AKT/mTOR signaling pathway can be triggered not only by extracellular signaling molecules and transmembrane receptors but also by alternative mechanisms.31, 35. The gene discussed is MTOR; the disease is renal cell carcinoma.